We are live on
!
Find out more
ECM
Ensemble Capital Management Portfolio holdings
AUM
$1.18B
1-Year Est. Return
41.81%
This Fund
S&P 500
This Quarter
Est. Return
+10.8%
1 Year Est. Return
+41.81%
3 Year Est. Return
+36.2%
5 Year Est. Return
+128.75%
10 Year Est. Return
+329.7%
AUM
$249M
AUM Growth
+$22.4M
(+9.9%)
Cap. Flow
+$1.47M
Cap. Flow
% of AUM
0.59%
Top 10 Holdings %
Top 10 Hldgs %
55.54%
Holding
52
New
1
Increased
18
Reduced
22
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TransDigm Group
TDG
|
+$3.9M |
| 2 |
Sensata Technologies
ST
|
+$3.72M |
| 3 |
First American
FAF
|
+$1.52M |
| 4 |
OCR
OMNICARE INC
OCR
|
+$1.32M |
| 5 |
Expeditors International
EXPD
|
+$1.15M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KBR
KBR
|
+$3.24M |
| 2 |
Teradata
TDC
|
+$2.32M |
| 3 |
Mastercard
MA
|
+$2.2M |
| 4 |
Teva Pharmaceuticals
TEVA
|
+$1.48M |
| 5 |
Williams Companies
WMB
|
+$954K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.93% |
| 2 | Financials | 17.69% |
| 3 | Energy | 15.75% |
| 4 | Industrials | 7.61% |
| 5 | Consumer Staples | 6.79% |
Similar funds
SEC
PP
GFS
GCAC
CAM
PRO
D
FTIS
Ensemble Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Ensemble Capital Management held 52 positions worth $249M, up 9.9% from $226M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Trading was light in Q4 2013: portfolio turnover was 3.8%. Ensemble Capital Management opened 1 new position and exited 1, leaving the 52-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Energy.
- Ensemble Capital Management's largest Q4 2013 buy was Energy Transfer Partners, L.P.: 6,000 shares worth $226K.
- Ensemble Capital Management added most to TransDigm Group in Q4 2013, an estimated $3.9M increase.
- Ensemble Capital Management's biggest Q4 2013 reduction was KBR, cutting an estimated $3.24M.
- Ensemble Capital Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $1.48M.
- Ensemble Capital Management's ten largest holdings make up 56% of its $249M portfolio in Q4 2013.
- Ensemble Capital Management opened 1 new position and closed 1 in Q4 2013.
- Ensemble Capital Management's portfolio value rose 9.9% quarter-over-quarter to $249M.
Based on Ensemble Capital Management's 13F filing for Q4 2013, filed 12 Feb 2014.